IL6 and COVID-19: Elevated levels of blood markers such as lactate dehydrogenase, D-dimers, procalcitonin, serum ferritin, and interleukin-6, as well as leucopoenia, were also found to be associated with worse COVID-19 outcomes, and therefore could potentially be used to monitor disease prognosis [89–91].